Introduction: This Position Statement presents the recommendations of the Italian Society of Endocrinology (SIE) to identify patients with Cushing’s syndrome in specific clinical settings. We set two overarching research questions: 1. Which subjects should be screened (“who” should be screened)? 2. Which is the most appropriate first-line test (“how” to screen) for screening? All suggestions/recommendations are evidence-based and directed at endocrinologists and other physicians who deal with patients who have presumptive Cushing’s syndrome. Methods: The recommendations, developed by a SIE committee, were formulated based on eight short-reviews commissioned to experts of the SIE Pituitary and Adrenal Clubs. These short reviews, published in a special issue of the Journal of Endocrinological Investigation, reported a comprehensive review of the literature, and each of them answered the two research questions (who and how to screen for hypercortisolism) in a specific population: (1) patients with type 2 diabetes mellitus or obesity; (2) patients with arterial hypertension; (3) children and adolescents; (4) women with hyperandrogenism and/or menstrual irregularities; (5) patients with osteoporosis and/or fractures; (6) patients with mood disorders; (7) patients with adrenal and pituitary incidentaloma; (8) patients with unusual infections or thrombotic events. Finally, 24 recommendations were formulated, based on the quality of available evidence. Conclusions: The evidence-based Position Statement provides clear and pragmatic advice regarding “who” and “how” to screen for Cushing’s syndrome. The suggestions/recommendations are developed for all health care providers, not only endocrinologists, to raise awareness on the diagnosis of Cushing’s syndrome.

Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology / F. Ceccato, M. Terzolo, F. Gatto, S. Cannavò, A. Bianchi, A.M. Isidori, A. Colao, D. Ferone, G. Aimaretti, F. Pecori Giraldi, G. Arnaldi, C. Scaroni. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - (2025). [Epub ahead of print] [10.1007/s40618-025-02758-3]

Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology

F. Pecori Giraldi;
2025

Abstract

Introduction: This Position Statement presents the recommendations of the Italian Society of Endocrinology (SIE) to identify patients with Cushing’s syndrome in specific clinical settings. We set two overarching research questions: 1. Which subjects should be screened (“who” should be screened)? 2. Which is the most appropriate first-line test (“how” to screen) for screening? All suggestions/recommendations are evidence-based and directed at endocrinologists and other physicians who deal with patients who have presumptive Cushing’s syndrome. Methods: The recommendations, developed by a SIE committee, were formulated based on eight short-reviews commissioned to experts of the SIE Pituitary and Adrenal Clubs. These short reviews, published in a special issue of the Journal of Endocrinological Investigation, reported a comprehensive review of the literature, and each of them answered the two research questions (who and how to screen for hypercortisolism) in a specific population: (1) patients with type 2 diabetes mellitus or obesity; (2) patients with arterial hypertension; (3) children and adolescents; (4) women with hyperandrogenism and/or menstrual irregularities; (5) patients with osteoporosis and/or fractures; (6) patients with mood disorders; (7) patients with adrenal and pituitary incidentaloma; (8) patients with unusual infections or thrombotic events. Finally, 24 recommendations were formulated, based on the quality of available evidence. Conclusions: The evidence-based Position Statement provides clear and pragmatic advice regarding “who” and “how” to screen for Cushing’s syndrome. The suggestions/recommendations are developed for all health care providers, not only endocrinologists, to raise awareness on the diagnosis of Cushing’s syndrome.
Cushing’s syndrome; Dexamethasone suppression test; Late-night salivary cortisol; Mild autonomous cortisol secretion; Non-neoplastic hypercortisolism; Urinary free cortisol
Settore MEDS-08/A - Endocrinologia
2025
9-dic-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
Ceccato JEI 2025.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 2.22 MB
Formato Adobe PDF
2.22 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1210323
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
  • OpenAlex 4
social impact